✦ LIBER ✦

A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer

✍ Scribed by Alberto J. Montero; Kiran Avancha; Stefan Glück; Gilberto Lopes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine in Combination with Paclitax

✍ Denise A. Yardley 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 40 KB

Gemcitabine in Combination with Paclitax

✍ Carlos Delfino 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 38 KB

Gemcitabine in Combination with Paclitax

✍ Ramon Colomer 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 39 KB

Adding bevacizumab to paclitaxel in the

✍ Kevin R. Fox 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 186 KB

Bevacizumab in Combination With Chemothe

✍ Howard S. Hochster 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 352 KB

Bevacizumab in the first-line treatment

✍ David Cameron 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 386 KB